Who owns Kezar Life Sciences Inc?
- Ticker: KZR
- CUSIP Number: 49372l100
Tip: Access positions for across all investors
Analyze quarterly positions in Kezar Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kezar Life Sciences stock
Who bought or sold Kezar Life Sciences Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Suvretta Capital Management | 7.2M | $6.5M | 0% | Mar 2024 |
|
| Avidity Partners Management | 5.0M | $4.5M | 0% | Mar 2024 |
|
| BlackRock | 4.6M | $4.2M | -7% | Mar 2024 |
|
| Vanguard Group | 3.1M | $2.8M | 1% | Mar 2024 |
|
| Sphera Funds Management | 2.1M | $1.8M | 0% | Mar 2024 |
|
| OrbiMed Advisors | 1.9M | $1.7M | 0% | Mar 2024 |
|
| Acadian Asset Management | 1.8M | $1.6M | 115% | Mar 2024 |
|
| Geode Capital Management | 1.4M | $1.2M | 6% | Mar 2024 |
|
| Two Sigma Investments | 1.3M | $1.2M | 7% | Mar 2024 |
|
| Two Sigma Advisers | 1.2M | $1.1M | -7% | Mar 2024 |
|
| Prosight Management | 964k | $869k | -80% | Mar 2024 |
|
| Ikarian Capital | 869k | $784k | 2% | Mar 2024 |
|
| Qiming U.S. Ventures Management | 829k | $785k | 0% | Dec 2023 |
|
| Millennium Management | 817k | $737k | -72% | Mar 2024 |
|
| Acuitas Investments | 691k | $623k | 100% | Mar 2024 |
|
| Tang Capital Management | 689k | $621k | 125% | Mar 2024 |
|
| Northern Trust | 515k | $465k | -10% | Mar 2024 |
|
| Citadel Advisors | 513k | $462k | 10% | Mar 2024 |
|
| D. E. Shaw & Co | 419k | $378k | 11% | Mar 2024 |
|
| Goldman Sachs Group | 405k | $365k | -9% | Mar 2024 |
|
| Nuveen Asset Management | 315k | $284k | 0% | Mar 2024 |
|
| GSA Capital Partners | 283k | $255k | 9% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 279k | $251k | 0% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 273k | $247k | 35% | Mar 2024 |
|
| ADAR1 Capital Management | 237k | $213k | 100% | Mar 2024 |
|
| PanAgora Asset Management | 233k | $210k | 177% | Mar 2024 |
|
| Charles Schwab Investment Management | 227k | $204k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 214k | $193k | -4% | Mar 2024 |
|
| Boothbay Fund Management | 151k | $136k | 12% | Mar 2024 |
|
| Marquette Asset Management | 126k | $114k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 109k | $99k | 2% | Mar 2024 |
|
| Bridgeway Capital Management | 109k | $98k | -65% | Mar 2024 |
|
| Morgan Stanley | 101k | $91k | -25% | Mar 2024 |
|
| Springbok Capital Management | 101k | $91k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 90k | $81k | -6% | Mar 2024 |
|
| Amundi | 82k | $65k | 0% | Mar 2024 |
|
| Alliancebernstein | 79k | $75k | -10% | Dec 2023 |
|
| UBS Group | 72k | $65k | 45% | Mar 2024 |
|
| Susquehanna International | 53k | $48k | -60% | Mar 2024 |
|
| Jacobs Levy Equity Management | 53k | $48k | -95% | Mar 2024 |
|
| Barclays | 50k | $45k | -49% | Mar 2024 |
|
| T. Rowe Price Associates | 48k | $43k | 3% | Mar 2024 |
|
| American International | 36k | $34k | 0% | Dec 2023 |
|
| Bank of America Corporation | 33k | $30k | -63% | Mar 2024 |
|
| Occudo Quantitative Strategies | 32k | $29k | -7% | Mar 2024 |
|
| Jpmorgan Chase & Co | 31k | $28k | -34% | Mar 2024 |
|
| Ironwood Investment Management | 28k | $25k | 11% | Mar 2024 |
|
| Fidelis Capital Partners | 27k | $25k | 100% | Mar 2024 |
|
| Mirae Asset Global Investments | 26k | $84k | 100% | Mar 2024 |
|
| SG Americas Securities | 25k | $22k | -44% | Mar 2024 |
|
| Jane Street | 25k | $22k | -65% | Mar 2024 |
|
| New York State Common Retirement Fund | 24k | $21k | 0% | Mar 2024 |
|
| Virtu Financial | 23k | $20k | 100% | Mar 2024 |
|
| FMR | 22k | $20k | 202% | Mar 2024 |
|
| Principal Financial Group | 22k | $20k | -19% | Mar 2024 |
|
| AQR Capital Management | 21k | $21k | 100% | Mar 2024 |
|
| Federated Investors | 20k | $19k | -26% | Dec 2023 |
|
| XTX Topco | 17k | $15k | -77% | Mar 2024 |
|
| Diversified Trust Company | 16k | $15k | 0% | Mar 2024 |
|
| Citigroup | 16k | $14k | 45% | Mar 2024 |
|
| Retirement Capital Strategies | 15k | $14k | 0% | Mar 2024 |
|
| ProShare Advisors | 13k | $12k | -9% | Mar 2024 |
|
| First Bank & Trust | 12k | $11k | 100% | Mar 2024 |
|
| H D Vest Advisory Services | 11k | $10k | 100% | Mar 2024 |
|
| Florida State Board of Administration | 10k | $32k | -45% | Mar 2024 |
|
| Legal & General Group | 6.8k | $6.1k | 0% | Mar 2024 |
|
| Tower Research Capital | 6.5k | $5.9k | -38% | Mar 2024 |
|
| Summit Investment Advisors | 4.1k | $3.7k | 0% | Mar 2024 |
|
| Cutler | 2.4k | $2.0k | 0% | Mar 2024 |
|
| Amalgamated Bank | 1.6k | $1.0k | -75% | Mar 2024 |
|
| Royal Bank of Canada | 1.6k | $0 | -93% | Mar 2024 |
|
| Capital Advisors | 1.6k | $1.0k | 100% | Mar 2024 |
|
| Atlantic Trust | 1.0k | $920.000000 | 100% | Mar 2024 |
|
| Simplex Trading | 933.00 | $0 | -73% | Mar 2024 |
|
| Advisor Group Holdings | 75.00 | $68.002500 | -44% | Mar 2024 |
|
| NISA Investment Advisors | 50.00 | $45.000000 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 13.00 | $11.000600 | 100% | Mar 2024 |
|
Who sold out of Kezar Life Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Granahan Investment Management | Sep 2023 | 1.5M | $1.7M |
| Squarepoint Ops | Dec 2023 | 187k | $177k |
| Hrt Financial | Dec 2023 | 104k | $98k |
| Algert Coldiron Investors | Sep 2023 | 57k | $68k |
| ALPS Advisors | Sep 2023 | 54k | $64k |
| RVW Wealth | Dec 2023 | 24k | $23k |
| Wexford Capital | Dec 2023 | 23k | $22k |
| California State Teachers Retirement System | Sep 2023 | 16k | $19k |
| Engineers Gate Manager | Sep 2023 | 14k | $16k |
| Quantbot Technologies | Sep 2023 | 7.9k | $9.4k |
| Pnc Financial Services | Dec 2023 | 187.00 | $176.995500 |